Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT
Xs. Qin et al., Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT, ONCOGENE, 18(30), 1999, pp. 4394-4400
DNA mismatch repair (MMR) stabilizes the cellular genome, Mice defective in
the MMR gene PMS2 are susceptible to spontaneous thymic lymphoma and sarco
mas, To determine the sensitivity of PMS2 knockout mice to environmental ca
rcinogens and the protective effect of O-6-methylguanine DIVA methyltransfe
rase (MGMT), heterozygous PMS2 knockout mice and human MGMT (hMGMT) transge
nic mice were mated and the PMS2(-/-) and PMS2(+/+) wit or without hMGMT of
fspring were treated at 5 weeks of age with 50 mg/kg N-methgl-N-nitrosourea
(MNU), MNU produces carcinogenic O-6-methylguanine (O-6-meG) adducts, resu
lting in thymic lymphoma in mice, which can be prevented in normal mice by
overexpression of hMGMT. A significantly higher incidence of thymic lymphom
as,vas observed in MNU-treated PMS2(-/-) mice, compared to wildtype PMS2(+/
+) mice (100 ra 52%; P < 0.001), The mean latency of lymphomas was also sig
nificantly shortened in PMS2(-/-) mice (81 vs 102 days, P<0.01), Transgenic
expression of hMGMT significantly but incompletely blocked MNU lymphomagen
esis in PMS2(-/-) mice. The incidence of lymphomas in PMS2(-/-)/hMGMT(+) mi
ce was reduced to 80% (P<0.01) and mean latency increased to 91 days (P<0.0
5), Thy mic lymphomagenesis was efficiently blocked in PMS2(+/+)/hMGMT(+) m
ice with rapid repair of O-6-meG, Since O-6-meG:T mismatches in MMR+ cells
may trigger mismatch repair resulting in abortive repair and cell death whe
reas in the absence of MMR, these mismatches are converted to A:T,,ve predi
cted that G to A point mutations in codon 12 of the K-ras gene would occur.
In this study, we found G to A point mutations in codon 12 of the K-ras ge
ne in many tumors. Thus, in MMR deficient tissues, methylating agents induc
e point mutations in cells with a higher rate of cell survival which togeth
er are potently carcinogenic in the thymus, These data suggest that PMS2 de
fective lymphomas may arise by the concerted action of environmental and pe
rhaps endogenous methylation of DNA coupled to genomic instability.